Defiance ETFs has launched its newest single-stock leveraged product, the Defiance Daily Target 2X Short OKLO ETF (NYSE:OKLS), offering tactical traders a high-octane means to express short-term bearish views on Oklo Inc (NYSE:OKLO). The launch adds to Defiance’s expanding suite of precision tools for experienced market participants who use leverage for daily, event-driven positioning rather than long-term exposure.
Also Read: Nuclear Stock Meltdown Continues For Oklo, NuScale, Nano
A New Tool For Short-Term, High-Conviction Bets
OKLS is designed to provide -2x the daily percentage return of Oklo’s share price, before fees and expenses. That is, if OKLO drops 1% in a session, OKLS would try to rise 2% on that same day — and vice versa. Like all daily leveraged ETFs, the fund resets its exposure every trading session, meaning it does not aim to track Oklo’s performance over time periods longer than one day. Compounding effects may lead to significant divergence over time, especially in volatile markets.
Spotlight On Oklo’s Nuclear Ambitions
Oklo has captured market attention due to its next-generation advanced nuclear microreactors which are compact, modular fission units designed to deliver clean and reliable power. The company’s path forward hinges on regulatory milestones, federal and utility partnerships, site licensing wins, and eventual deployment of demonstration reactors.
Interest in companies developing alternative reactor technologies has heightened amid momentum in nuclear innovation, energy security concerns, and newfound urgency behind global decarbonization efforts. This will lead short-term traders to potential opportunities for amplification around catalysts, including regulatory announcements, earnings updates, or policy shifts.
With OKLS, Defiance ETFs is targeting that demographic directly — traders seeking sharper tools for fast-moving markets, where direction, timing, and conviction matter as much as the story behind the stock itself.
Read Next:
Image: Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

